ArticleCancer research and treatment2023

Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.

Miso Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.